Cantitate/Preț
Produs

Kidney Cancer: Cancer Treatment and Research, cartea 116

Editat de Robert A. Figlin
en Limba Engleză Paperback – noi 2012
Kidney cancer is a heterogenous disease. This book covers: -new surgical approaches which are becoming the standard, i.e., nephon sparing, laporascopic, minimally invasive techniques;
-new staging and prognostic capabilities;
-evolving therapeutic options include, cell based vaccine, gene and antibody therapy;
-molecular genetics allow for a better understanding of the various types of kidney cancer.
Kidney Cancer is a comprehensive review covering present and future surgical approaches, staging and prognostic factors, currently accepted and future plans for prevention, diagnosis and treatment. Contributing authors to this book are internationally recognized specialists in this disease. This book will be useful to the specialist (oncologist and urologist), primary care physicians, patients and family members dealing with kidney cancer.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 91622 lei  38-45 zile
  Springer Us – noi 2012 91622 lei  38-45 zile
Hardback (1) 92439 lei  38-45 zile
  Springer Us – 31 oct 2003 92439 lei  38-45 zile

Din seria Cancer Treatment and Research

Preț: 91622 lei

Preț vechi: 96445 lei
-5%

Puncte Express: 1374

Preț estimativ în valută:
17554 19014$ 15053£

Carte tipărită la comandă

Livrare economică 06-13 mai

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781461350835
ISBN-10: 1461350832
Pagini: 260
Ilustrații: IX, 246 p.
Dimensiuni: 155 x 235 x 14 mm
Greutate: 0.37 kg
Ediția:Softcover reprint of the original 1st ed. 2003
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research

Locul publicării:New York, NY, United States

Public țintă

Research

Descriere

Kidney cancer is a heterogenous disease. This book covers: -new surgical approaches which are becoming the standard, i.e., nephon sparing, laporascopic, minimally invasive techniques;
-new staging and prognostic capabilities;
-evolving therapeutic options include, cell based vaccine, gene and antibody therapy;
-molecular genetics allow for a better understanding of the various types of kidney cancer.
Kidney Cancer is a comprehensive review covering present and future surgical approaches, staging and prognostic factors, currently accepted and future plans for prevention, diagnosis and treatment. Contributing authors to this book are internationally recognized specialists in this disease. This book will be useful to the specialist (oncologist and urologist), primary care physicians, patients and family members dealing with kidney cancer.

Cuprins

Part I: Introduction. Molecular Genetics of Kidney Cancer; M. Zimmer, O. Iliopoulos. Mechanisms of Immune Dysfunction in Renal Cell Carcinoma; I.H. Derweesh, C. Tannenbaum, P. Rayman, J.H. Finke. New Algorithms for the Staging of Kidney Cancer; D. Leibovici, Sella, I.Y. Siegel, A. Zisman. Basic Biology and Clinical Behavior of Kidney Cancer; Ken-ryu Han, A.J. Pantuck, A.S. Belldegrun. Part II: Kidney Cancer: Surgical Approaches. Nephron Sparing Surgery; I.H. Derweesh, A.C. Novick. Laparoscopic Radical Nephrectomy and Minimally Invasive Surgery for Kidney Cancer; N.K. Janzen, K. Perry, P. Schulam. Role of Nephrectomy in Metastatic Kidney Cancer; P.M. Yonover, S.K. Sharma, R.C. Flanigan. Part III: Metastatic Renal Cell Carcinoma: Current and Future Approaches. Prognostic Factors for Metastatic Kidney Cancer; B.J. Drucker, R.J. Motzer. Interleukin-2 Based Therapy for Kidney Cancer; J.P. Dutcher. The Role of Systemic Chemotherapy in the Treatment of Kidney Cancer; C.M. George, W.M. Stadler. Cell, Gene, and Vaccine Based Strategies in Kidney Cancer; B.J. Gitlitz, R.A. Figlin. Monoclonal Antibody Therapy of Kidney Cancer; E. Oosterwijk, C.R. Divgi, A. Brouwers, O.C. Boerman, S.M. Larson, L.J. Old, P. Mulders. Allogeneic Hematopoetic Stem Cell Transplantation for Cytokine Refractory Renal Cell Carcinoma; D. Drachenberg, R.W. Childs. Novel Therapies for Renal Cell Carcinoma; S. Syed, A.W. Tolcher.

Recenzii

"This text provides a comprehensive overview of kidney cancer. Investigative leaders in the field discuss the genetic, biologic and clinical manifestations of the disease. Modern therapy is reviewed with commentary on future alternatives and novel compounds."
(Steven T. Rosen, M.D., Series Editor)

Notă biografică

Robert A. Figlin, Professor of Medicine, Urology, Departments of Medicine and Urology, Division of Hematology/Oncology, University of California, Los Angeles School of Medicine, USA, holds the Henry Alvin and Carrie L. Meinhardt Chair in Urologic Oncology. He serves as Medical Director of the Thoracic and Genitourinary Oncology Program. He is a Senior Clinical Investigator in areas of genitourinary and thoracic oncology and has served as Principal Investigator on Phase I, II, and III trials. He serves as Chairman of the UCLA Medical Institutional Review Board and as a member of the UCLA Human Research Policy Board.